Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit.
Saved in:
| Title: | Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit. |
|---|---|
| Authors: | Lin EP; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee; Division of Pulmonary Medicine, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan; Department of Medical Research, Taipei Medical University Hospital, Taipei, Taiwan., Hsu CY; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee., Chiou JF; Department of Radiation Oncology, Taipei Medical University Hospital, Taipei, Taiwan; Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan., Berry L; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee., Horn L; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Bunn P; Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado., Yang JC; Department of Oncology, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan., Yang PC; Department of Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan., Adjei AA; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Shyr Y; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee; Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei, Taiwan. Electronic address: yu.shyr@vumc.org. |
| Source: | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2022 Dec; Vol. 17 (12), pp. 1365-1374. Date of Electronic Publication: 2022 Aug 30. |
| Publication Type: | Meta-Analysis; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36049656 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lin+EP%22">Lin EP</searchLink>; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee; Division of Pulmonary Medicine, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan; Department of Medical Research, Taipei Medical University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Hsu+CY%22">Hsu CY</searchLink>; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Chiou+JF%22">Chiou JF</searchLink>; Department of Radiation Oncology, Taipei Medical University Hospital, Taipei, Taiwan; Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Berry+L%22">Berry L</searchLink>; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Horn+L%22">Horn L</searchLink>; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Bunn+P%22">Bunn P</searchLink>; Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.<br /><searchLink fieldCode="AU" term="%22Yang+JC%22">Yang JC</searchLink>; Department of Oncology, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yang+PC%22">Yang PC</searchLink>; Department of Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Adjei+AA%22">Adjei AA</searchLink>; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Shyr+Y%22">Shyr Y</searchLink>; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, Tennessee; Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei, Taiwan. Electronic address: yu.shyr@vumc.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101274235%22">Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer</searchLink> [J Thorac Oncol] 2022 Dec; Vol. 17 (12), pp. 1365-1374. <i>Date of Electronic Publication: </i>2022 Aug 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Meta-Analysis; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101274235 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1556-1380 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215560864%22">15560864 </searchLink><i>NLM ISO Abbreviation: </i>J Thorac Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36049656 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jtho.2022.08.010 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1365 Titles: – TitleFull: Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lin EP – PersonEntity: Name: NameFull: Hsu CY – PersonEntity: Name: NameFull: Chiou JF – PersonEntity: Name: NameFull: Berry L – PersonEntity: Name: NameFull: Horn L – PersonEntity: Name: NameFull: Bunn P – PersonEntity: Name: NameFull: Yang JC – PersonEntity: Name: NameFull: Yang PC – PersonEntity: Name: NameFull: Adjei AA – PersonEntity: Name: NameFull: Shyr Y IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2022 Dec Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1556-1380 Numbering: – Type: volume Value: 17 – Type: issue Value: 12 Titles: – TitleFull: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Type: main |
| ResultId | 1 |
